Growth patterns during the first two years of a child’s life may shape pubertal growth and adult height, but have little effect on pubertal timing, according to research presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE). The findings highlight the importance of early-life growth, which could be used as a marker to predict future growth, development and health.

Women who experience infertility are more likely to develop heart and blood vessel conditions later in life, with younger women and those who undergo fertility treatments at a greater risk. The findings, presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE), highlight the importance of considering a woman’s reproductive history when assessing her long-term heart health.

Women who experience menopause before the age of 50 — and especially before the age of 45 — are more likely to develop fatty liver disease and its related metabolic risk factors within one year after menopause, according to research presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE). This study is the largest to assess this association over five years and suggests that the age of natural menopause should be considered part of the cardio-metabolic risk assessment in women.

Boys born to mothers who have polycystic ovary syndrome (PCOS) or who have higher levels of testosterone during the third trimester are more likely to be less physically active at age 7, according to research presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE). Testosterone levels or PCOS in the mothers were not associated with physical activity in girls, but 7-year-old girls whose mothers had higher testosterone levels during pregnancy had lower muscle strength. The findings highlight the important role that maternal testosterone and PCOS may play in future development in boys and girls independently. 

Men with fertility issues have lower levels of phosphate in the blood than average, according to research presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE). In addition, low phosphate concentrations in the blood were associated with reduced sperm motility in infertile men. The findings can help researchers improve the understanding of the biological factors involved in male reproductive health, which could lead to new fertility treatments.

Three-year-old boys are more likely to have a shorter anogenital distance when their mothers have high levels of phthalates in their urine, according to research presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE). In girls, the direct exposure to phthalates was associated with a shorter anogenital distance. The findings highlight how exposure to environmental pollutants can cause alterations in genital measurements during the first three years of life, which may affect sexual development and fertility later in life.

Individuals taking steroid tablets for more than 3 months are over 6 times more likely to be diagnosed with adrenal insufficiency than those treated with non-steroidal anti-inflammatory drugs, according to research presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE). In addition, they have a greater risk of being hospitalised for adrenal insufficiency, while long-term users of inhaled steroids have an increased risk of developing adrenal insufficiency but without any increase in the number of hospitalisations. The findings highlight the importance of using an appropriate substitute treatment, such as hydrocortisone, in order to prevent the onset of adrenal insufficiency.